To evaluate the role of HSD17B13 in driving steatotic liver, we proceeded to directly knock down the elevated levels of this protein in adult mice with HFD‐induced MASLD thereby circumventing the lack of a protective effect of Hsd17b13 whole‐body, total genetic knockout from birth in mice. Here, HSD17B13 is linked to metabolic dysfunction-associated steatotic liver disease.